BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33299528)

  • 1. Mild Oxidative Stress Reduces NRF2 SUMOylation to Promote
    Xu J; Guo H; Xing Z; Zhang W; He J; Cheng J; Cai R
    Oxid Med Cell Longev; 2020; 2020():6240125. PubMed ID: 33299528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma.
    Best SA; Ding S; Kersbergen A; Dong X; Song JY; Xie Y; Reljic B; Li K; Vince JE; Rathi V; Wright GM; Ritchie ME; Sutherland KD
    Nat Commun; 2019 Sep; 10(1):4190. PubMed ID: 31519898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
    Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
    Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-1-propenylmercaptocysteine protects murine hepatocytes against oxidative stress via persulfidation of Keap1 and activation of Nrf2.
    Tocmo R; Parkin K
    Free Radic Biol Med; 2019 Nov; 143():164-175. PubMed ID: 31349040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM13 inhibits cell proliferation and induces autophagy in lung adenocarcinoma by regulating KEAP1/NRF2 pathway.
    Yu B; Zhou Y; He J
    Cell Cycle; 2023 Jun; 22(12):1496-1513. PubMed ID: 37245083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
    DeNicola GM; Karreth FA; Humpton TJ; Gopinathan A; Wei C; Frese K; Mangal D; Yu KH; Yeo CJ; Calhoun ES; Scrimieri F; Winter JM; Hruban RH; Iacobuzio-Donahue C; Kern SE; Blair IA; Tuveson DA
    Nature; 2011 Jul; 475(7354):106-9. PubMed ID: 21734707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous activation of Nrf2 and its target antioxidant enzymes leads to arsenite-induced malignant transformation of human bronchial epithelial cells.
    Yang X; Wang D; Ma Y; Xu X; Zhu Z; Wang X; Deng H; Li C; Chen M; Tong J; Yamanaka K; An Y
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):231-9. PubMed ID: 26420645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2-Keap1 pathway-mediated effects of resveratrol on oxidative stress and apoptosis in hydrogen peroxide-treated rheumatoid arthritis fibroblast-like synoviocytes.
    Zhang Y; Wang G; Wang T; Cao W; Zhang L; Chen X
    Ann N Y Acad Sci; 2019 Dec; 1457(1):166-178. PubMed ID: 31475364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis.
    Guo H; Xu J; Zheng Q; He J; Zhou W; Wang K; Huang X; Fan Q; Ma J; Cheng J; Mei W; Xing R; Cai R
    Cancer Lett; 2019 Dec; 466():39-48. PubMed ID: 31546024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical Outcomes.
    Singh A; Daemen A; Nickles D; Jeon SM; Foreman O; Sudini K; Gnad F; Lajoie S; Gour N; Mitzner W; Chatterjee S; Choi EJ; Ravishankar B; Rappaport A; Patil N; McCleland M; Johnson L; Acquaah-Mensah G; Gabrielson E; Biswal S; Hatzivassiliou G
    Clin Cancer Res; 2021 Feb; 27(3):877-888. PubMed ID: 33077574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma.
    Yuan G; Hu B; Ma J; Zhang C; Xie H; Wei T; Yang Y; Ni B
    Cancer Med; 2023 Mar; 12(6):7258-7272. PubMed ID: 36504353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDA-7/IL-24 inhibits Nrf2-mediated antioxidant response through activation of p38 pathway and inhibition of ERK pathway involved in cancer cell apoptosis.
    Tian H; Zhang D; Gao Z; Li H; Zhang B; Zhang Q; Li L; Cheng Q; Pei D; Zheng J
    Cancer Gene Ther; 2014 Oct; 21(10):416-26. PubMed ID: 25236495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors.
    Hayashi M; Kuga A; Suzuki M; Panda H; Kitamura H; Motohashi H; Yamamoto M
    Cancer Res; 2020 Aug; 80(16):3331-3344. PubMed ID: 32636316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection.
    Hu B; Wei H; Song Y; Chen M; Fan Z; Qiu R; Zhu W; Xu W; Wang F
    J Virol; 2020 May; 94(10):. PubMed ID: 32161178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy.
    Zhang D; Hou Z; Aldrich KE; Lockwood L; Odom AL; Liby KT
    Mol Cancer Ther; 2021 Sep; 20(9):1692-1701. PubMed ID: 34158350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of KEAP1/NRF2 stress signaling involved in the molecular basis of hemin-induced cytotoxicity in human pro-erythroid K562 cells.
    Georgiou-Siafis SK; Tsiftsoglou AS
    Biochem Pharmacol; 2020 May; 175():113900. PubMed ID: 32156661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway.
    Lin X; Bai D; Wei Z; Zhang Y; Huang Y; Deng H; Huang X
    PLoS One; 2019; 14(5):e0216711. PubMed ID: 31112588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of KEAP1-targeting PROTAC and its antioxidant properties: In vitro and in vivo.
    Park SY; Gurung R; Hwang JH; Kang JH; Jung HJ; Zeb A; Hwang JI; Park SJ; Maeng HJ; Shin D; Oh SH
    Redox Biol; 2023 Aug; 64():102783. PubMed ID: 37348157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.